Tris (dibenzylideneacetone) dipalladium (Tris DBA), an N-myristoyltransferase 1 inhibitor, is effective against melanoma growth in vitro and in vivo Meeting Abstract
| Authors: | Arbiser, I. L.; Bhandarkar, S.; Bromberg, J.; Selvakumar, P.; Sharma, R. K.; Fried, L.; Govindarajan, B. |
| Abstract Title: | Tris (dibenzylideneacetone) dipalladium (Tris DBA), an N-myristoyltransferase 1 inhibitor, is effective against melanoma growth in vitro and in vivo |
| Meeting Title: | International Investigative Dermatology 2008 (IID 2008) |
| Journal Title: | Journal of Investigative Dermatology |
| Volume: | 128 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2008 May 14-17 |
| Meeting Location: | Kyoto, Japan |
| ISSN: | 0022-202X |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2008-04-01 |
| Start Page: | S212 |
| Language: | English |
| ACCESSION: | WOS:000254353801264 |
| PROVIDER: | wos |
| DOI: | 10.1038/jid.2008.93 |
| PUBMED: | 18340337 |
| Notes: | Meeting Abstract: 1271 -- "Source: Wos" |
